Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05756348 · ClinicalTrials.gov registry record · NA
Durability of Two Skin Barrier Protectants (SBP)
A NA study, sponsored by Medline Industries.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT05756348 is a NA study that has completed, run by Medline Industries. The registered enrollment target is 42 participants.
The verdict
NCT05756348, a NA study, has completed, sponsored by Medline Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The current study will evaluate the duration of wear and durability of two commercially available SBPs: Medline Marathon® XL (extra long) No Sting Cyanoacrylate Skin Protectant (henceforth referred to as "Marathon®") and 3M™ Cavilon™ Advanced Skin Protectant (henceforth referred to as "Cavilon™").
Interventions
- DEVICE Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™ Advanced Skin Protectant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2022-10-06 |
| Est. Completion | 2022-11-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05756348
The ClinicalTrials.gov registry entry for NCT05756348 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medline Industries, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™ Advanced Skin Protectant is the first listed.
NCT05756348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05756348 about?
NCT05756348 is a clinical study titled "Durability of Two Skin Barrier Protectants (SBP)". The current study will evaluate the duration of wear and durability of two commercially available SBPs: Medline Marathon® XL (extra long) No Sting Cyanoacrylate Skin Protectant (henceforth referred to as "Marathon®") and 3M™ Cavilon™ Advanced Skin Protectant (henceforth referred to as "Cavilon™").
What is the current status of trial NCT05756348?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2022-10-06. Estimated completion is 2022-11-22.
What interventions are being tested in trial NCT05756348?
The interventions under investigation include: Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™ Advanced Skin Protectant (DEVICE).
Who is sponsoring clinical trial NCT05756348?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.